192 related articles for article (PubMed ID: 23534718)
21. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
[TBL] [Abstract][Full Text] [Related]
22. Common fragile genes and digestive tract cancers.
Kuroki T; Tajima Y; Furui J; Kanematsu T
Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185
[TBL] [Abstract][Full Text] [Related]
23. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
[TBL] [Abstract][Full Text] [Related]
24. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
[TBL] [Abstract][Full Text] [Related]
25. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
[TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
Kim JS; Kim H; Shim YM; Han J; Park J; Kim DH
Carcinogenesis; 2004 Nov; 25(11):2165-71. PubMed ID: 15231689
[TBL] [Abstract][Full Text] [Related]
27. A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.
Loyo M; Brait M; Kim MS; Ostrow KL; Jie CC; Chuang AY; Califano JA; Liégeois NJ; Begum S; Westra WH; Hoque MO; Tao Q; Sidransky D
Int J Cancer; 2011 Mar; 128(6):1393-403. PubMed ID: 20473931
[TBL] [Abstract][Full Text] [Related]
28. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.
Roy D; Sin SH; Damania B; Dittmer DP
Blood; 2011 Aug; 118(7):e32-9. PubMed ID: 21685375
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract][Full Text] [Related]
31. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
32. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients.
Haroun RA; Zakhary NI; Mohamed MR; Abdelrahman AM; Kandil EI; Shalaby KA
Asian Pac J Cancer Prev; 2014; 15(10):4281-7. PubMed ID: 24935385
[TBL] [Abstract][Full Text] [Related]
33. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas.
Pavelić K; Krizanac S; Cacev T; Hadzija MP; Radosević S; Crnić I; Levanat S; Kapitanović S
Mol Med; 2001 Jul; 7(7):442-53. PubMed ID: 11683369
[TBL] [Abstract][Full Text] [Related]
34. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
[TBL] [Abstract][Full Text] [Related]
35. Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.
Lee HL; Cheng HL; Liu YF; Chou MC; Yang SF; Chou YE
PLoS One; 2017; 12(4):e0176141. PubMed ID: 28426730
[TBL] [Abstract][Full Text] [Related]
36. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
[TBL] [Abstract][Full Text] [Related]
37. Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (BMI-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver Cancer Tissue and Normal Liver Tissue.
Yu J; Hu M; Chen W; Wen Z
Med Sci Monit; 2018 Sep; 24():6673-6679. PubMed ID: 30242144
[TBL] [Abstract][Full Text] [Related]
38. Genetic alterations of the WWOX gene in breast cancer.
Ekizoglu S; Muslumanoglu M; Dalay N; Buyru N
Med Oncol; 2012 Sep; 29(3):1529-35. PubMed ID: 21983861
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between the expression of fragile histidine (FHIT) and the development of vulvar carcinoma].
Chu YX; Zheng A; Xi MR; Zhang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):218-20. PubMed ID: 16608079
[TBL] [Abstract][Full Text] [Related]
40. High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma.
Xu YF; Ren XY; Li YQ; He QM; Tang XR; Sun Y; Shao JY; Jia WH; Kang TB; Zeng MS; Liu N; Ma J
BMC Cancer; 2015 Apr; 15():332. PubMed ID: 25925041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]